Quote | Cytek Biosciences Inc. (NASDAQ:CTKB)
Last: | $6.18 |
---|---|
Change Percent: | 0.49% |
Open: | $6.07 |
Close: | $6.18 |
High: | $6.275 |
Low: | $6.05 |
Volume: | 513,865 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
News | Cytek Biosciences Inc. (NASDAQ:CTKB)
2024-05-12 03:24:07 ET Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Conference Call May 08, 2024, 04:30 PM ET Company Participants Paul Goodson - Investor Relations Wenbin Jiang - Chief Executive Officer William McCombe - Chief Financial Officer Conferen...
2024-05-08 17:57:57 ET More on Cytek Biosciences Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader Cytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Cytek Biosciences Read the full article on S...
Message Board Posts | Cytek Biosciences Inc. (NASDAQ:CTKB)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Cytek Biosciences Inc. Company Name:
CTKB Stock Symbol:
NASDAQ Market:
Cytek Biosciences, Inc. (NASDAQ: CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. Th...
FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the first quarter ended March 31, 2024. Recent ...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...